Ellex has advised Specialist VC as the lead investor on the EUR 1.75 million seed round for Estonian medtech company Nanordica Medical.
Superangel and Amalfi also participated in the round.
Specialist VC is a venture capital firm.
Founded in 2019, Nanordica Medical is a spin-off of the National Institute of Chemical Physics and Biophysics in Estonia Nanordica, which invented and patented antibacterial nanotechnology.
The investment round enables Nanordica to "develop and bring to market innovative wound care products based on nanotechnology," commented Specialist VC Founding Partner Gerri Kodres. "We were inspired by the extraordinary determination and resilience of Nanordica Medical’s founder team. The company’s innovative wound care solution has the potential to positively impact the lives of chronic wound patients across the world."
The Ellex team included Partner Antti Perli, Counsel Rutt Vark, Senior Associates Merlin Liis-Toomela and Hanna Pahk, Tax Counsel Dmitri Rozenblat, and Lawyer Hegle Parna.
